| Literature DB >> 33299222 |
Maria Luisa Fiorella1, Paolo Greco1, Luigi Maria Madami1, Orazio Valerio Giannico2, Vito Pontillo1, Nicola Quaranta1.
Abstract
INTRODUCTION: Deep neck space infections (DNSIs) are a group of infective suppurative diseases involving deep neck spaces and cervical fascia. Necrotising and septic evolutions are rare, but severe complications can dramatically affect the prognosis and should be promptly managed. Clinical examination often has low sensitivity, although instrumental diagnosis may delay te treatment. We investigated two laboratory tools, LRINEC (Laboratory Risk Indicator for the Necrotizing fasciitis) and NLR (neutrophil to lymphocyte ratio), in the expectation to find a rapidly available predictive indicator that may help in distinguishing necrotising complications and/or systemic septic involvement.Entities:
Keywords: LRINEC; NLR; neck; necrotizing fasciitis; sepsis
Mesh:
Year: 2020 PMID: 33299222 PMCID: PMC7726647 DOI: 10.14639/0392-100X-N0790
Source DB: PubMed Journal: Acta Otorhinolaryngol Ital ISSN: 0392-100X Impact factor: 2.124
LRINEC score calculating model.
| Variable, Unit | Score |
|---|---|
| < 150 | 0 |
| ≥ 150 | 4 |
| > 13.5 | 0 |
| 11-13.5 | 1 |
| < 11 | 2 |
| < 15 | 0 |
| 15-25 | 1 |
| > 25 | 2 |
| ≥ 135 | 0 |
| <135 | 2 |
| ≤ 141 | 0 |
| > 141 | 2 |
| ≤ 180 | 0 |
| > 180 | 1 |
Clinical findings in our series.
| Sources of infection | N | % |
|---|---|---|
| Unknown | 51 | 43.2 |
| Odontogenic | 33 | 27.9 |
| Recurrent tonsillitis | 11 | 9.3 |
| Sialolithiasis | 8 | 6.8 |
| Previous neck procedures (FNAB/surgery) | 4 | 3.4 |
| Neck cysts | 3 | 2.5 |
| Lymphadenopathy | 3 | 2.5 |
| Mastoiditis | 2 | 1.7 |
| Other | 3 | 2.5 |
| Submandibular | 34 | 28.81 |
| Parapharyngeal | 24 | 20.34 |
| Parotid space | 13 | 11.02 |
| Oral pelvis/base of tongue | 5 | 4.237 |
| Retropharyngeal | 3 | 2.542 |
| Multiple localisations | 24 | 20.34 |
| Other | 15 | 12.71 |
| Hypertension | 25 | 21.19 |
| Diabetes | 16 | 13.56 |
| Cardiopathy | 10 | 8.475 |
| Autoimmune diseases | 5 | 4.237 |
| Endocrinopathy (except diabetes) | 4 | 3.39 |
| Nephropathy | 4 | 3.39 |
| Neoplasia | 3 | 2.542 |
| Chronic obstructive pulmonary disease (COPD) | 3 | 2.542 |
| None | 48 | 40.68 |
Kruskal-Wallis and Wilcoxon Tests.
| LRINEC median (IQR) | NLR median (IQR) | NLR x LINREC median (IQR) | |||
|---|---|---|---|---|---|
| No sepsis | 4.5 (3.3) | 7.0 (6.9) | 29.4 (43.7) | ||
| Sepsis | 5.0 (3.0) | 10.3 (11.3) | 59.2 (71.7) | ||
| Septic shock | 8.0 (2.0) | 13.4 (8.2) | 107.3 (82.6) | ||
| (Kruskal-Wallis Test) | P = 0.003 | P = 0.001 | P < 0.001 | ||
| Yes | 8.0 (3.5) | 15.0 (17.5) | 86.3 (113.9) | ||
| No | 5.0 (3.5) | 9.2 (9.5) | 39.2 (72.5) | ||
| (Wilcoxon Test) | P = 0.020 | P = 0.041 | P = 0.010 | ||
Pairwise comparison for Sepsis Score.
| Wilcoxon rank sum test | P-value |
|---|---|
| No Sepsis / Sepsis | 0.039 |
| No Sepsis / Septic shock | 0.004 |
| Sepsis / Septic shock | 0.039 |
| No Sepsis / Sepsis | 0.011 |
| No Sepsis / Septic shock | 0.005 |
| Sepsis / Septic shock | 0.203 |
| No Sepsis / Sepsis | 0.011 |
| No Sepsis / Septic shock | < 0.001 |
| Sepsis / Septic shock | 0.034 |
ROC indicators.
| Discriminating septic involvement (sepsis/septic shock) | ||||||
|---|---|---|---|---|---|---|
| Test | AUC | Cut-off | Sens. | Spec. | PV+ | PV- |
| LRINEC | 0.672 | 7.0 | 42.6 | 86.1 | 82.1 | 50.0 |
| NLR | 0.679 | 8.2 | 74.2 | 61.5 | 71.0 | 65.3 |
| NLRxLRINEC | 0.716 | 30.4 | 81.5 | 52.8 | 72.1 | 65.5 |
| LRINEC | 0.716 | 7.0 | 54.5 | 84.8 | 6.9 | 66.7 |
| NLR | 0.681 | 17.5 | 50.0 | 84.9 | 6.2 | 72.7 |
| NLRxLRINEC | 0.742 | 43.5 | 90.9 | 59.5 | 2.1 | 76.2 |